Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Open-Label, Multicenter Extension Study for Patients Completing Treatment Phase of a Rigel-Sponsored R935788 Studies

ClinicalTrials.gov ID: NCT00805467

Public ClinicalTrials.gov record NCT00805467. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 12:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Multicenter Extension Study to Evaluate the Safety of R935788 in Patients With Rheumatoid Arthritis Who Have Completed the Treatment Phase of a Rigel-Sponsored R935788 Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this new research study is to gain additional information about how safe and effective R935788 is over a longer period of time.

Study identification

NCT ID
NCT00805467
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
AstraZeneca
Industry
Enrollment
624 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2008 (Type not available)
Primary completion
Aug 2013 (Actual)
Completion
Aug 2013 (Actual)
Last update posted
Jun 25, 2014

2008 – 2013

United States locations

U.S. sites
35
U.S. states
17
U.S. cities
35
Facility City State ZIP Site status
Research Site La Jolla California — —
Research Site Palm Desert California — —
Research Site Palo Alto California — —
Research Site San Diego California — —
Research Site Santa Maria California — —
Research Site Hamden Connecticut — —
Research Site Washington D.C. District of Columbia — —
Research Site Aventura Florida — —
Research Site Boca Raton Florida — —
Research Site Gainesville Florida — —
Research Site Ocala Florida — —
Research Site Orange Park Florida — —
Research Site Orlando Florida — —
Research Site South Miami Florida — —
Research Site Venice Florida — —
Research Site Boise Idaho — —
Research Site Coeur d'Alene Idaho — —
Research Site South Bend Indiana — —
Research Site Elizabethtown Kentucky — —
Research Site Cumberland Maryland — —
Research Site Hagerstown Maryland — —
Research Site Lansing Michigan — —
Research Site Omaha Nebraska — —
Research Site Roslyn New York — —
Research Site Smithtown New York — —
Research Site Raleigh North Carolina — —
Research Site Mayfiled Village Ohio — —
Research Site Erie Pennsylvania — —
Research Site Willow Grove Pennsylvania — —
Research Site Wyomissing Pennsylvania — —
Research Site Jackson Tennessee — —
Research Site Austin Texas — —
Research Site San Antonio Texas — —
Research Site Oklahoma City Washington — —
Research Site Spokane Washington — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 41 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00805467, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 25, 2014 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00805467 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →